2024 annual financial data
Barinthus Biotherapeutics 2024 Operating margin
Barinthus Biotherapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -454.07%.
Operating income was -67,970,000 USD and net income was -61,074,000 USD.
Operating cash flow was -28,940,000 USD.
Get free Barinthus Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,969,000 USD
- Operating income
- -67,970,000 USD
- Net income
- -61,074,000 USD
- Operating cash flow
- -28,940,000 USD